Advertisement

Advertisement

GNPX Stock Latest News

Genprex Highlights New Reqorsa Preclinical Data at AACR

Company AnnouncementsGenprex Highlights New Reqorsa Preclinical Data at AACR

Genprex collaborators present on use of Reqorsa at AACR meeting

PremiumThe Fly

Genprex collaborators present on use of Reqorsa at AACR meeting

7d ago

Genprex Secures Key Global Patents for REQORSA Therapy

PremiumCompany Announcements

Genprex Secures Key Global Patents for REQORSA Therapy

30d ago

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

PremiumThe Fly

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

30d ago

Genprex Gains Australian Patent Acceptance for REQORSA Therapy

PremiumCompany Announcements

Genprex Gains Australian Patent Acceptance for REQORSA Therapy

1M ago

Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia

PremiumThe FlyGenprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia

1M ago

Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring

Company Announcements

Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring

2M ago

Genprex advances GPX-002 diabetes gene therapy program

Company Announcements

Genprex advances GPX-002 diabetes gene therapy program

3M ago

Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy

PremiumCompany Announcements

Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy

3M ago

Genprex reports ‘positive’ preclinical data from study of GPX-002

PremiumThe Fly

Genprex reports ‘positive’ preclinical data from study of GPX-002

3M ago

Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy

PremiumThe Fly

Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy

4M ago

Genprex Announces $75 Million Stock Offering

PremiumCompany Announcements

Genprex Announces $75 Million Stock Offering

4M ago

Genprex files to sell 1.28M shares of common stock for holders

PremiumThe FlyGenprex files to sell 1.28M shares of common stock for holders

4M ago

Genprex Expands Clinical Trials with New Site Addition

Company Announcements

Genprex Expands Clinical Trials with New Site Addition

4M ago

Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3

The Fly

Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3

4M ago

Genprex Secures U.S. Patent for Reqorsa® Therapy

PremiumCompany Announcements

Genprex Secures U.S. Patent for Reqorsa® Therapy

4M ago

Genprex granted U.S. patenet for Reqorsa Gene Therapy in cancer

PremiumThe Fly

Genprex granted U.S. patenet for Reqorsa Gene Therapy in cancer

4M ago

Genprex on path to receive European patent for Reqorsa in cancer

PremiumThe Fly

Genprex on path to receive European patent for Reqorsa in cancer

5M ago

Genprex Secures European Patent for Reqorsa® Therapy

PremiumCompany Announcements

Genprex Secures European Patent for Reqorsa® Therapy

5M ago

Genprex Announces Securities Purchase Agreement and Offering

PremiumCompany AnnouncementsGenprex Announces Securities Purchase Agreement and Offering

5M ago

Genprex trading resumes

The Fly

Genprex trading resumes

5M ago

Genprex trading halted, volatility trading pause

The Fly

Genprex trading halted, volatility trading pause

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >